Vanderbilt Vaccine Research Program — Nashville, Tennessee

Vanderbilt Vaccine Research Program is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Vanderbilt Vaccine Research Program has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Asthmatic, Respiratory Syncytial Virus, Human Metapneumovirus.

Sponsors: Vanderbilt University Medical Center, ModernaTX, Inc..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Vaccine Research Program?

Vanderbilt Vaccine Research Program has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Vaccine Research Program conducted?

Vanderbilt Vaccine Research Program has 2 clinical trials on record, with 1 currently active. Their work covers Asthmatic, Respiratory Syncytial Virus, Human Metapneumovirus.

Is Vanderbilt Vaccine Research Program accredited by Crixeo Health?

Vanderbilt Vaccine Research Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Vaccine Research Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.